AIM – Your Supply Chain Connection published the third and final paper in its series on parallel trade in the EU pharmaceutical market introducing a governance framework built around six capabilities.

AIM, a Blue Matter company, is a trusted supply chain specialist for life science companies. We help pharmaceutical, biotech, and other life science companies, design, build, expand and optimize end-to-end supply chains — from source to patient. Fully dedicated to the life sciences industry, AIM supports companies across Europe, North America, and global markets, from clinical-stage innovators preparing for launch to established organizations managing and optimizing complex commercial supply chains. Our services span three core areas: • End-to-End Supply Chain Strategy & Optimization • Launch Supply Chain Design & Delivery • Operational Supply Chain Support We support clients across the full supply chain lifecycle — from strategy and network design to implementation, operational management, and continuous improvement. Our expertise covers biologics, specialty pharmaceuticals, rare diseases, cell & gene therapies, ATMPs, diagnostics, and other complex modalities. What sets AIM apart is the combination of deep specialization and hands-on execution. We bring practical expertise in product requirements, commercial distribution, and patient-critical operations, alongside proven methodologies that help clients turn strategy into measurable results. Whether it’s a major product launch with no room for delay, scaling and optimizing existing operations, or providing interim operational support during critical transitions, AIM works hands-on alongside clients to deliver resilient, scalable, and high-performing supply chains. Founded in 2009 and part of Blue Matter since 2020, AIM combines specialized supply chain expertise with broader strategic capabilities offered through Blue Matter, giving clients access to integrated support from strategy through execution.

Founded 2009